Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Vaccines
Research from G.J Kotwal and co-researchers yields new findings on HIV/AIDS vaccines
August 6th, 2008
A new study, 'Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs),' is now available. According to recent research from the United States, "Genetic diversity and hypermutation contribute to difficulties in developing a vaccine against viruses like HIV and influenza. There are currently no known immune correlates of protection against HIV." "This has made the development of a vaccine against HIV that would provide sterilizing immunity in the near future an...
Source: Vaccine Weekly (2008-08-06)
|
